Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Haemonetics: Fiscal Q2 Earnings Snapshot

Haemonetics: Fiscal Q2 Earnings Snapshot

HAE : 88.17 (-1.18%)
Haemonetics: Fiscal Q1 Earnings Snapshot

Haemonetics: Fiscal Q1 Earnings Snapshot

HAE : 88.17 (-1.18%)
Haemonetics: Fiscal Q4 Earnings Snapshot

Haemonetics: Fiscal Q4 Earnings Snapshot

HAE : 88.17 (-1.18%)
Haemonetics: Fiscal Q3 Earnings Snapshot

Haemonetics: Fiscal Q3 Earnings Snapshot

HAE : 88.17 (-1.18%)
HAEMONETICS COMPLETES ACQUISITION OF OPSENS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 88.17 (-1.18%)
OPS.TO : 2.90 (unch)
Stocks in play: OpSens Inc.

Announces that the Superior Court of Québec issued a final order today in connection with the previously ...

HAE : 88.17 (-1.18%)
OPS.TO : 2.90 (unch)
OPSENS RECEIVES FINAL ORDER FOR ARRANGEMENT WITH HAEMONETICS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 88.17 (-1.18%)
OPS.TO : 2.90 (unch)
OPSENS' SHAREHOLDERS APPROVE ARRANGEMENT WITH HAEMONETICS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 88.17 (-1.18%)
OPS.TO : 2.90 (unch)
OPSENS OBTAINS REGULATORY CLEARANCE OF ARRANGEMENT IN THE UNITED STATES AND CANADA; REGULATORY APPROVALS CONDITION SATISFIED

All amounts in this press release are in Canadian dollars. Clearance under both the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the...

OPSSF : 2.1389 (+0.64%)
HAE : 88.17 (-1.18%)
OPS.TO : 2.90 (unch)
INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS SHAREHOLDERS VOTE "FOR" OPSENS INC. PLAN OF ARRANGEMENT WITH HAEMONETICS CORPORATION

All amounts in this press release are in Canadian dollars. Leading independent proxy advisor says cash offer provides meaningful 50.3% premium to OpSens Inc.'s...

OPSSF : 2.1389 (+0.64%)
HAE : 88.17 (-1.18%)
OPS.TO : 2.90 (unch)

Barchart Exclusives

Can Nvidia Stock Rally After Q3 Earnings This Week?
Valued at a market cap of $3.5 trillion, Nvidia is a big tech giant that continues to grow at an enviable pace, even as major earnings beats have become routine. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar